loading...| Preferred Name |
Sitagliptin Phosphate |
|
| Synonyms |
|
|
| Definitions |
The phosphate salt form of sitagliptin, an orally available, competitive, beta-amino acid-derived inhibitor of dipeptidyl peptidase 4 (DDP-4) with hypoglycemic activity. Sitagliptin may cause an increased risk in the development of pancreatitis. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C73811 |
|
| CAS_Registry |
654671-77-9 |
|
| Chemical_Formula |
C16H15F6N5O.H2O.H3O4P |
|
| code |
C73811 |
|
| Contributing_Source |
CTRP FDA |
|
| definition |
The phosphate salt form of sitagliptin, an orally available, competitive, beta-amino acid-derived inhibitor of dipeptidyl peptidase 4 (DDP-4) with hypoglycemic activity. Sitagliptin may cause an increased risk in the development of pancreatitis. |
|
| Display_Name |
Sitagliptin Phosphate |
|
| FDA_UNII_Code |
TS63EW8X6F |
|
| Has_Free_Acid_Or_Base_Form | ||
| Has_Target | ||
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C176424 |
|
| label |
Sitagliptin Phosphate |
|
| Legacy Concept Name |
Sitagliptin_Phosphate |
|
| NCI_Drug_Dictionary_ID |
640174 |
|
| PDQ_Closed_Trial_Search_ID |
640174 |
|
| PDQ_Open_Trial_Search_ID |
640174 |
|
| Preferred_Name |
Sitagliptin Phosphate |
|
| prefixIRI |
NCIT:C73811 |
|
| prefLabel |
Sitagliptin Phosphate |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C1667080 |
|
| subClassOf |